The mean age at MTC diagnosis of those with compound mutations showed a trend towards younger ages relative to those with single mutations, and there seems to be no need to change the risk grade.
← all excerpts
Spectrum of Germline RET variants identified by targeted sequencing and associated Multiple Endocrine Neoplasia type 2 susceptibility in China.
1
—
—